T. Rowe Price Associates’s EyePoint Inc EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Buy
124,989
+18,851
+18% +$252K ﹤0.01% 2058
2026
Q1
$1.37M Buy
106,138
+13,568
+15% +$203K ﹤0.01% 1992
2025
Q4
$1.69M Buy
92,570
+10,658
+13% +$151K ﹤0.01% 1830
2025
Q3
$1.17M Sell
81,912
-1,797
-2% -$20.7K ﹤0.01% 1993
2025
Q2
$788K Sell
83,709
-1,270,305
-94% -$8.77M ﹤0.01% 2090
2025
Q1
$7.34M Sell
1,354,014
-790,733
-37% -$5.53M ﹤0.01% 1169
2024
Q4
$16M Sell
2,144,747
-347,466
-14% -$3.23M ﹤0.01% 1041
2024
Q3
$19.9M Sell
2,492,213
-10,158
-0.4% -$89.2K ﹤0.01% 994
2024
Q2
$21.8M Buy
2,502,371
+36,556
+1% +$511K ﹤0.01% 945
2024
Q1
$51M Sell
2,465,815
-56,889
-2% -$1.41M 0.01% 726
2023
Q4
$58.3M Buy
2,522,704
+1,148,358
+84% +$12.8M 0.01% 661
2023
Q3
$11M Buy
+1,374,346
New +$15.1M ﹤0.01% 1063

Other funds holding EYPT

T. Rowe Price Associates's EYPT Position: Q2 2026 in Review

T. Rowe Price Associates increased its EyePoint Inc (EYPT) stake by 18% in Q2 2026, buying an estimated $252K and bringing the position to 124,989 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

T. Rowe Price Associates first reported a position in EYPT in Q3 2023 and has held it in 12 quarters since. The position peaked at $58.3M in Q4 2023. 189 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • T. Rowe Price Associates held 124,989 shares of EyePoint Inc worth $1.79M as of Q2 2026.
  • T. Rowe Price Associates bought 18,851 EyePoint Inc shares in Q2 2026, an estimated $252K.
  • EyePoint Inc made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2058 holding.
  • T. Rowe Price Associates first reported a position in EyePoint Inc in Q3 2023 and has held it in 12 quarters since.
  • T. Rowe Price Associates's EyePoint Inc position peaked at $58.3M in Q4 2023.
  • 189 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.